Alcon Financial Statements From 2010 to 2025

ALC Stock  CHF 80.64  0.60  0.74%   
Alcon AG financial statements provide useful quarterly and yearly information to potential Alcon AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Alcon AG financial statements helps investors assess Alcon AG's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Alcon AG's valuation are summarized below:
Alcon AG does not presently have any fundamental signals for analysis.
Check Alcon AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alcon AG's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alcon financial statements analysis is a perfect complement when working with Alcon AG Valuation or Volatility modules.
  
This module can also supplement various Alcon AG Technical models . Check out the analysis of Alcon AG Correlation against competitors.
For more information on how to buy Alcon Stock please use our How to Invest in Alcon AG guide.

Alcon AG Company Current Valuation Analysis

Alcon AG's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Alcon AG Current Valuation

    
  35.45 B  
Most of Alcon AG's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alcon AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Alcon AG has a Current Valuation of 35.45 B. This is 146.78% higher than that of the Healthcare sector and 287.68% higher than that of the Medical Instruments & Supplies industry. The current valuation for all Switzerland stocks is 113.22% lower than that of the firm.

Alcon AG Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alcon AG's current stock value. Our valuation model uses many indicators to compare Alcon AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alcon AG competition to find correlations between indicators driving Alcon AG's intrinsic value. More Info.
Alcon AG is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.74  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Alcon AG is roughly  1.36 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alcon AG's earnings, one of the primary drivers of an investment's value.

About Alcon AG Financial Statements

Alcon AG investors use historical fundamental indicators, such as Alcon AG's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Alcon AG. Please read more on our technical analysis and fundamental analysis pages.
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. operates independently of Novartis AG as of April 9, 2019. ALCON N operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 20000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Alcon Stock Analysis

When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.